These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 13432604)

  • 1. [Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
    BERNARD J; MATHE G; WEIL M
    Sang; 1957; 28(1):80-2. PubMed ID: 13432604
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trials of treatment by p-(di-2-chloroethylamino)phenylbutyric acid in Hodgkin's disease, chronic lymphoid leukemia and different sarcomas of lymphatic tissue; study of one hundred cases].
    BERNARD J; MATHE G; WEIL M
    Rev Fr Etud Clin Biol; 1956 Dec; 1(10):1121-32. PubMed ID: 13408766
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
    KIELER J
    Acta radiol; 1951 Dec; 36(6):461-8. PubMed ID: 14902587
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
    KLIMA R; HORNISCHER R
    Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Hodgkin's disease and the lymphosarcomas.
    MEYER OO
    J Am Med Assoc; 1954 Jan; 154(2):114-20. PubMed ID: 13108678
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of the resistant stages of Hodgkin's disease and lymphoblastic diseases.
    HOCHMAN A; ICKOWICZ M
    Br J Radiol; 1954 Aug; 27(320):467-9. PubMed ID: 13182191
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nitrogen mustard therapy of various cases of malignant lymphogranuloma and lymphosarcoma].
    NARDI FL
    Accad Medica; 1952 Apr; 67(4):169-77. PubMed ID: 12984986
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimentation with actinomycin].
    HUGUENIN R; TRUHAUT R; BOURDIN JS
    Presse Med (1893); 1954 May; 62(35):740. PubMed ID: 13177453
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with CB 1348 (NN-di(2-chloroethyl, -P-aminophenylbutyric acid) in the treatment of chronic lymphatic leukaemia.
    HANSEN PB
    Acta radiol; 1957 Mar; 47(3):210-16. PubMed ID: 13424344
    [No Abstract]   [Full Text] [Related]  

  • 10. Early experience with p-(N, N-di-2-chloroethyl)-aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia.
    ALTMAN SJ; HAUT A; CARTWRIGHT GE; WINTROBE MM
    Cancer; 1956; 9(3):512-7. PubMed ID: 13330000
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hemoblastosis with triethylene melamine].
    LINKE A; LASCH HG
    Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
    ZULIK R
    Arzneimittelforschung; 1958 Jun; 8(6):360-1. PubMed ID: 13546105
    [No Abstract]   [Full Text] [Related]  

  • 13. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
    HAMBLY CK; ROBERTSON TI
    Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of malignant lymphomas and lymphadenoses with leukeran.
    LIBANSKY J; CHUDOMEL V; BRABEC V; SOCHMAN J
    Neoplasma; 1959; 6():415-24. PubMed ID: 14416684
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of nitrogen mustard in the treatment of lymphatic diseases of a malignant type].
    RABENKO J; CORREA URQUIZA LM
    Prensa Med Argent; 1959 Oct; 46():2549-54. PubMed ID: 14435621
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value and action of cytostatics in malignant lymphatic system diseases].
    FLEISCHHACKER H; STACHER A
    Wien Z Inn Med; 1962 May; 43():200-8. PubMed ID: 13893500
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
    GOODMAN LS; WINTROBE MM
    J Am Med Assoc; 1946 Sep; 132():126-32. PubMed ID: 20997191
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitrogen mustards in the treatment of Hodgkin's disease and lymphosarcoma.
    SHERRY M
    South Med J; 1948 Feb; 41(2):118-29. PubMed ID: 18898249
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of the effectiveness of HN2 and cyclophosphamide in bronchogenic carcinoma, Hodgkin's disease and lymphosarcoma.
    SPEAR PW; PATNO ME
    Cancer Chemother Rep; 1962 Feb; 16():413-5. PubMed ID: 13915594
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of the effect of degranol.
    SANDOR L; CERNY V; UJHAZY V; WINKLER A
    Neoplasma; 1959; 6():179-82. PubMed ID: 14441442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.